PBV Insights
Log In Get Started
Menu
News
26 Feb 2026

Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I Invest in Zeroharm Sciences Private Limited

"Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I on their primary investment in Zeroharm Sciences Private Limited, a nutraceutical company."

Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I on their primary investment in Zeroharm Sciences Private Limited. The transaction comprised a primary investment by the two funds into Zeroharm Sciences Private Limited, a nutraceutical company. Khaitan & Co represented Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I with a team composed by: Sanchit Agarwal (Partner), Pulkit Chaturvedi (Principal Associate), Aditi Gupta (Senior Associate), Jubin Jay (Senior Associate), Daryl Menezes (Associate), Shriya Garg (Associate), and Sameer Parihar (Associate).
Read the full story

Register for free to access daily news.

Register Free
Already registered? Login
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.